Stocks
Adaptive Biotechnologies (ADPT) EBITDA margin US GAAP (year values) |
|||||||||
| 2020 | 2021 | 2022 | 2023 | 2023 | LTM ? | CAGR 5 years ? | |||
| EBITDA margin, % | ? | -153.6% | -134.3% | -104.9% | -105.3% | -105.3% | -99.7% | ||
| Changes by years, y/y, % | -63pp | +19pp | +29pp | 0pp | 0pp | +6.0% | |||
Adaptive Biotechnologies. EBITDA margin, %
Adaptive Biotechnologies. EBITDA margin, changes, pp
Adaptive Biotechnologies (ADPT) EBITDA margin US GAAP (quarter values) |
||||||||
| 2023Q2 | 2023Q3 | 2023Q4 | 2023Q4 | 2024Q1 | LTM ? | |||
| EBITDA margin, % | ? | -78.8% | -134.4% | -87.9% | -87.9% | -93.9% | -99.7% | |
| Changes by years, y/y, % | +30pp | -52pp | -22pp | -22pp | +36pp | |||
| Changes by quarters, q/q, % | +51pp | -56pp | +46pp | 0pp | -6pp | |||
